Exploring Key Insights of the Postpartum Depression Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Rapidly is the Postpartum Depression Market Expected to Expand Between 2025 and 2034 Based on Current Trends?
In recent times, the market size for postpartum depression has expanded dramatically. There will be a growth from $12.15 billion in 2024 to $16.09 billion in 2025, indicating a compound annual growth rate (CAGR) of 32.4%. The substantial growth during the historical period is due to factors such as heightened consciousness about maternal mental health, progression in research, public health measures, and amplified screenings.
Expectations are high for a substantial enlargement of the postpartum depression market in the forthcoming years. The market is predicted to expand to $49.4 billion in 2029, showcasing a compound annual growth rate (CAGR) of 32.4%. The projected growth within this forecast period can be accredited to elements such as telehealth services, advancements in pharmacology, legislation pertaining to maternal mental health, and broadening of the mental health workforce. Preponderant trends within the same timeframe include the incorporation of care models, implementation of peer support programs, use of perinatal mental health applications, and the development of tools for mental health screening.
How Are the key drivers expanding the growth of the Postpartum Depression Market?
Anticipated growth in the postpartum depression market is thought to be fueled by a surge in postpartum depression incidents. Postpartum depression represents intense post-birth concern, often supplemented by physical symptoms. Postnatal depression is commonly coincident with postpartum anxiety and can potentially start at any point during the first year post-birth. Both medication and psychotherapy, alternatively known as talk therapy or professional mental health counseling, or a combination of both are typically applied to treat postpartum depression, contributing to market growth. For instance, a February 2022 study involving 1.1 million mothers conducted by the US-based University of Virginia School of Medicine (UVA SoM) found the Risk of postpartum depression is greatest among new mothers, those under 25, and mothers of twins. Postpartum depression symptoms were reported by 10% of women aged 18-24, which was the highest across all age groups. Twin mothers presented slightly higher rates of postpartum depression at 11.3% as opposed to 8.3% for single-child mothers. Hence, the rising cases of postpartum depression are bolstering the postpartum depression market.
Postpartum Depression Market Propellant: Surge in Childbirth Numbers Fuels Growth
Get Your Free Sample of the Global Postpartum Depression Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp
Which Key Players Are Shaping the Future of the Postpartum Depression Market?
Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.
How Are the Latest Trends Influencing the Growth of the Postpartum Depression Market?
In the postpartum depression market, companies strive to remain competitive by consistently innovating new products. The currently limited options for treatment necessitate the development of therapies that act more rapidly and novel modes of care delivery for postpartum depression. For example, Biogen Inc. and Sage Therapeutics Inc., both American companies, one a biotech and the other a biopharmaceutical, declared in February 2023 that the FDA has given its acceptance for an NDA for their experimental drug, zuranolone, to combat major depressive disorder (MDD) and postpartum depression (PPD). The experimental drug, zuranolone, is being trialed as an everyday, 14-day, fast-acting oral treatment for those struggling with MDD and PPD. Zuranolone, a neuroactive hormone, works as a positive modulator for GABA-A receptors, which represents an unprecedented mechanism of action. The expectation is that it will address depression swiftly by restoring the brain networks that regulate mood, arousal, behavior, and also cognition, that have experienced significant disruption.
Get Instant Access to the Global Postpartum Depression Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report
Which Segments Play a Crucial Role in the Expansion of the Postpartum Depression Market?
The postpartum depression market covered in this report is segmented –
1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types
2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments
3) By Route of Administration: Oral, Parenteral, Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings
2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks
3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors
4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms
5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety
6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings
7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum
What Regions Are At the Forefront of Postpartum Depression Market Expansion?
North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Can We Define the Postpartum Depression Market and Its Key Components?
Postpartum depression (PPD) refers to a condition, which is a type of mood disorder that affects some women after giving birth and can remain undiagnosed for long periods of time. It is characterized by feelings of sadness, hopelessness and a lack of interest or pleasure in once-enjoyable activities.
Browse Through More Similar Reports By The Business Research Company:
Telepsychiatry Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/telepsychiatry-global-market-report
Behavioral and Mental Health Software Global Market Report 2024
Residential Substance Abuse And Mental Health Facilities Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
